LU79335A1 - Procede de preparation de derives d'acetamides utiles notamment en therapeutique - Google Patents

Procede de preparation de derives d'acetamides utiles notamment en therapeutique

Info

Publication number
LU79335A1
LU79335A1 LU79335A LU79335A LU79335A1 LU 79335 A1 LU79335 A1 LU 79335A1 LU 79335 A LU79335 A LU 79335A LU 79335 A LU79335 A LU 79335A LU 79335 A1 LU79335 A1 LU 79335A1
Authority
LU
Luxembourg
Prior art keywords
therapeutics
preparation
derivatives useful
useful particularly
acetamide derivatives
Prior art date
Application number
LU79335A
Other languages
English (en)
French (fr)
Inventor
L Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of LU79335A1 publication Critical patent/LU79335A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU79335A 1977-03-31 1978-03-29 Procede de preparation de derives d'acetamides utiles notamment en therapeutique LU79335A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13579/77A GB1584462A (en) 1977-03-31 1977-03-31 N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
LU79335A1 true LU79335A1 (fr) 1978-09-28

Family

ID=10025527

Family Applications (2)

Application Number Title Priority Date Filing Date
LU79335A LU79335A1 (fr) 1977-03-31 1978-03-29 Procede de preparation de derives d'acetamides utiles notamment en therapeutique
LU90153C LU90153I2 (fr) 1977-03-31 1997-10-17 Modiodal 100 mg

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU90153C LU90153I2 (fr) 1977-03-31 1997-10-17 Modiodal 100 mg

Country Status (14)

Country Link
US (1) US4177290A (xx)
JP (1) JPS53121724A (xx)
BE (1) BE865468A (xx)
CA (1) CA1091679A (xx)
CH (1) CH628026A5 (xx)
DE (2) DE19875010I2 (xx)
DK (1) DK152207C (xx)
ES (1) ES468378A1 (xx)
FR (1) FR2385693A1 (xx)
GB (1) GB1584462A (xx)
IE (1) IE46566B1 (xx)
IT (1) IT1094041B (xx)
LU (2) LU79335A1 (xx)
NL (2) NL188692C (xx)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393026A (en) * 1980-06-19 1983-07-12 Petrolite Corporation Compounds containing sulfur and amino groups
US4616085A (en) * 1980-06-19 1986-10-07 Petrolite Corporation Thioethers of imidazolines
US4539404A (en) * 1980-06-19 1985-09-03 Petrolite Corporation Pyrimidines containing sulfur and amino groups as corrosion inhibitors
US4332967A (en) * 1980-06-19 1982-06-01 Petrolite Corporation Compounds containing sulfur and amino groups
US4450138A (en) * 1981-11-10 1984-05-22 Petrolite Corporation Processes for inhibiting corrosion using compounds containing sulfur and amino groups
US4684507A (en) * 1981-11-10 1987-08-04 Petrolite Corporation Process of corrosion inhibition using compounds containing sulfur and amino groups
US4450137A (en) * 1981-11-10 1984-05-22 Petrolite Corporation Processes for inhibiting corrosion using compounds containing sulfur and amino groups
FR2528039A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Nouveaux derives de benzylsulfinylacetamide, utilisation en therapeutique et procede de preparation
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2528038B2 (fr) * 1982-06-04 1985-08-09 Lafon Labor Derives de benzhydrylsulfinylacetamide et leur utilisation en therapeutique
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2584666B1 (fr) * 1985-07-10 1989-06-16 Champion Spark Plug Europ Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
FR2611709B1 (fr) * 1987-02-26 1989-06-09 Lafon Labor 2-(benzhydrylsulfonyl)acetamide, son procede de preparation et son application en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
JPH0421903U (xx) * 1990-06-18 1992-02-24
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (xx) * 1993-06-22 1995-09-08 Lafon Labor
FR2707637B1 (fr) * 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
CN1249932A (zh) 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
NZ524359A (en) * 2000-07-27 2005-06-24 Teva Pharma Crystalline and pure modafinil, and process of preparing the same
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
IL155322A0 (en) 2000-10-11 2003-11-23 Cephalon Inc Compositions comprising modafinil compounds
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
IL143106A (en) 2001-05-13 2005-11-20 Chemagis Ltd Process for the preparation of diphenylmethylthioacetamide
ES2281527T3 (es) * 2001-05-25 2007-10-01 Cephalon, Inc. Formulaciones farmaceuticas solidas que comprenden modafinilo.
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
ITMI20020991A1 (it) * 2002-05-10 2003-11-10 Dinamite Dipharma S P A In For Procedimento per la sintesi del modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
TW200413296A (en) * 2002-08-09 2004-08-01 Cephalon France Modafinil polymorphic forms
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CN1305842C (zh) * 2002-12-31 2007-03-21 中国人民解放军军事医学科学院放射与辐射医学研究所 取代亚砜基乙酰胺的制备方法
EP1437345A1 (en) 2003-01-13 2004-07-14 Organisation de Synthese Mondiale Orsymonde Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
US7186860B2 (en) * 2003-01-31 2007-03-06 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
MXPA05008088A (es) * 2003-02-24 2005-09-21 Mallinckrodt Inc Proceso mejorado para preparar benzhidril tioacetamida.
CA2420180A1 (en) * 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
US20070066996A1 (en) * 2003-03-17 2007-03-22 Katzman Daniel E Modafinil-based neurorehabilitation of impaired neurological function associated with brian injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
ES2330321T3 (es) * 2003-05-16 2009-12-09 Cephalon France Procedimiento de sintesis de modafinilo.
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (en) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited A process for the preparation of diphenylmethylsulfinyl derivatives
EP1516869A1 (en) * 2003-09-19 2005-03-23 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
ATE410410T1 (de) * 2003-10-23 2008-10-15 Mallinckrodt Inc Verbessertes verfahren zur herstellung von benzhydrylthioacetamid.
US20050137264A1 (en) * 2003-12-22 2005-06-23 Patel Ashish A. Modafinil compositions
CN1980888B (zh) * 2004-02-06 2011-04-13 赛福伦公司 莫达芬尼组合物
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
EP1586559A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
EP1586560A1 (en) 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7297817B2 (en) 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
EP1586561A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7119214B2 (en) 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US20060024370A1 (en) 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
CN100393699C (zh) * 2005-03-10 2008-06-11 浙江工业大学 2-(二苯基甲基亚硫酰基)乙酰胺的合成方法
EP1702915A1 (en) * 2005-03-14 2006-09-20 Cephalon France Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
CN1321978C (zh) * 2005-04-29 2007-06-20 浙江工业大学 一种2-(二苯基甲基亚硫酰基)乙酰胺的合成方法
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
ITMI20051971A1 (it) * 2005-10-18 2007-04-19 Dipharma Spa Procedimento per la preparazione di - modafinil
EP1973873A2 (en) * 2005-12-09 2008-10-01 Mallinckrodt Inc. Processes for the preparation of modafinil and analogs thereof
EP2056811B8 (en) 2006-08-14 2018-03-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
WO2008077127A2 (en) * 2006-12-19 2008-06-26 Lavin Thomas N Use of modafinil to treat restless leg syndrome
US9289403B2 (en) * 2007-03-09 2016-03-22 The Board of Trustees of the University of Arizona Use of modafinil to treat spasticity
EP2155664A2 (en) * 2007-06-04 2010-02-24 Generics Ýuk¨Limited Novel process
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
US7960586B2 (en) * 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090082461A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched modafinil
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
MX2012007813A (es) * 2010-01-07 2012-08-01 Vivus Inc Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
CN102976985A (zh) * 2011-09-07 2013-03-20 大连大学 一锅法合成二苯甲基亚磺酰基乙酰胺及其类似物的方法
WO2014138518A2 (en) * 2013-03-08 2014-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
CN104341327A (zh) * 2013-08-08 2015-02-11 中国人民解放军63975部队 多卤素取代2-(二苯甲基亚硫酰基)乙酰胺类化合物及其立体异构体
CN104045588A (zh) * 2014-06-11 2014-09-17 江苏斯威森生物医药工程研究中心有限公司 一种2-(4,4’-二卤-二苯基甲基亚磺酰)乙酰胺的合成方法
CN104672118A (zh) * 2014-12-12 2015-06-03 上海泓海荣通医药技术有限公司 一种莫达非尼多晶体的合成方法
EP3391886A1 (en) 2017-04-19 2018-10-24 Novartis AG The use of a h3r inverse agonist for the treatment of shift work disorder
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
AU2019359549A1 (en) 2018-10-11 2021-03-25 Novartis Ag The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT336589B (de) * 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
DE2546319C2 (de) * 1975-10-16 1986-02-27 Dr. Karl Thomae Gmbh, 7950 Biberach Cyclohexylphenyl-Derivate, Verfahren zu deren Herstellung und diese enthaltende Mittel
GB1574822A (en) * 1976-03-23 1980-09-10 Lafon Labor Acetohydroxamic acid derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
DE2809625A1 (de) 1978-10-05
JPS629103B2 (xx) 1987-02-26
DK152207B (da) 1988-02-08
DE19875010I2 (de) 2001-06-13
DE2809625C2 (de) 1985-05-09
ES468378A1 (es) 1978-12-16
CH628026A5 (fr) 1982-02-15
IT1094041B (it) 1985-07-26
FR2385693B1 (xx) 1980-04-11
NL188692C (nl) 1992-09-01
IT7821872A0 (it) 1978-03-31
GB1584462A (en) 1981-02-11
FR2385693A1 (fr) 1978-10-27
DK140878A (da) 1978-10-01
LU90153I2 (fr) 1998-02-16
JPS53121724A (en) 1978-10-24
IE780433L (en) 1978-09-30
US4177290A (en) 1979-12-04
DK152207C (da) 1988-07-11
NL980003I2 (nl) 1998-05-06
CA1091679A (en) 1980-12-16
NL980003I1 (nl) 1998-03-02
NL7803432A (nl) 1978-10-03
BE865468A (fr) 1978-10-02
IE46566B1 (en) 1983-07-27

Similar Documents

Publication Publication Date Title
LU79335A1 (fr) Procede de preparation de derives d'acetamides utiles notamment en therapeutique
BE857541A (fr) Derives d'acide prostanoique et leur procede de preparation
FR2383187A1 (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
BE864112A (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
FR2340327A1 (fr) Procede de preparation d'homopolymeres et copolymeres d'alpha-mono-olefines
BE869721A (fr) Derives d'acides cycloalcoylindenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
PT65853A (fr) Procede de preparation des derives d'amino-alcools
BE868594A (fr) Derives alpha-acetyleniques d'amines utiles notamment comme inhibiteurs de certaines decarboxylases et leur procede de preparation
FR2349590A1 (fr) Forme cristalline du sel de la l-lysine et du cefuroxime, son procede de preparation et son application therapeutique
BE827870A (fr) Derives d'emidazole et leur procede de preparation
FR2305416A1 (fr) Procede de preparation de tricosene-(9) et d'heneicosene-(9)
BE841538A (fr) Procede de preparation de derives de carbanate et d'uree
FR2352783A1 (fr) Derives polyprenyl-carboxyliques, leur procede de preparation et leur application en therapeutique
FR2353556A1 (fr) Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique
BE853157A (fr) Procede de preparation de cyanures d'acyle
BE863402A (fr) Azacycloalcanes, azacycloalcenes et derives de ceux-ci, leur procede de preparation et leur application en therapeutique
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
BE841165A (fr) Derives d'acides 8-aza-prostanoiques et leur procede de preparation
BE855121A (fr) Derives d'uracile et procede pour leur preparation
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique
BE853739A (fr) Composition d'amino-alcools et leur procede de preparation
BE833079A (fr) Derives n-acyles de l'orgoteine, utiles notamment comme anti-inflammatoires, et leur procede de preparation
BE840944A (fr) Procede de preparation d'acides carboxy-alcane-phosphoniques et d'acides carboxy-alkyl-phosphiniques
MC1058A1 (fr) Procede de preparation d'hydroxocobalamine et de ses sels
BE863020A (fr) Nouveaux derives de l'ergoline, leurs applications en therapeutique et procede pour leur preparation

Legal Events

Date Code Title Description
CCP Supplementary protection certificate

Free format text: 90153, EXPIRES: 20030329